These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7036285)
1. Immunologically defined prognostic subgroups as predictors of response to BCG immunotherapy. Reid JW; Cannon GB; Perlin E; Blom J; Connor R; Herberman RB Recent Results Cancer Res; 1982; 80():219-26. PubMed ID: 7036285 [TBL] [Abstract][Full Text] [Related]
2. Intrapleural BCG immunotherapy of lung cancer patients. Maver C; Kausel H; Lininger L; McKneally M Recent Results Cancer Res; 1982; 80():227-31. PubMed ID: 7036286 [No Abstract] [Full Text] [Related]
3. Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group Study. McCracken JD; Chen T; White J; Samson M; Stephens R; Coltman CA; Saiki J; Lane M; Bonnet J; McGavran M Cancer; 1982 Jun; 49(11):2252-8. PubMed ID: 6280836 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease. Gross NJ; Eddie-Quartey AC Cancer; 1976 May; 37(5):2183-93. PubMed ID: 769946 [TBL] [Abstract][Full Text] [Related]
5. [BCG immunotherapy as an adjuvant to surgery in lung cancer. An analysis of lymphocyte subsets of the peripheral blood using monoclonal antibodies]. Miyazawa N; Tsuchiya R; Naruke T; Yoneyama T; Suemasu K Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):56-61. PubMed ID: 3892115 [No Abstract] [Full Text] [Related]
6. Immunotherapy of human lung cancer with BCG cell-wall skeleton. Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710 [TBL] [Abstract][Full Text] [Related]
7. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients. Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442 [TBL] [Abstract][Full Text] [Related]
9. Immunological monitoring and immunotherapy in carcinoma of the lung. Weese JL; Herberman RB; Perlin E; Mills M; Heims W; Blom J; Green D; Reid J; Bellinger S; Law I; McCoy JL; Dean JH; Cannon GB; Djeu J Int J Cancer; 1976 Dec; 18(6):739-49. PubMed ID: 186417 [TBL] [Abstract][Full Text] [Related]
10. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer. Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results. Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205 [TBL] [Abstract][Full Text] [Related]
12. Immune status in lung cancer: effects of BCG immunotherapy. Gross NJ; Eddie-Quartey AC Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255 [TBL] [Abstract][Full Text] [Related]
13. Follow-up results from a randomized trial for T3 and T4 breast cancer patients: previous BCG immunotherapy improves response to chemotherapy in the relapse patient. Serrou B; Sancho-Garnier H; Cappelaere P; Plagne R; Metz R; Schneider M; Chollet P; Namer N; Pujol H; Gary-Bobo J; Meyer G; Mathé G Recent Results Cancer Res; 1982; 80():157-61. PubMed ID: 7036278 [TBL] [Abstract][Full Text] [Related]
14. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy]. Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535 [No Abstract] [Full Text] [Related]
15. Intrapleural BCG in postsurgical stage I non-small cell lung cancer. Macchiarini P; Mussi A; Angeletti CA Anticancer Res; 1989; 9(2):391-3. PubMed ID: 2546484 [TBL] [Abstract][Full Text] [Related]
16. Interim results of EORTC protocol 08742: comparison, after irradiation of locally advanced squamous cell bronchial carcinoma, of abstention, immunotherapy, combination chemotherapy, or chemoimmunotherapy. Israel L; Depiere A; Dalesio O Recent Results Cancer Res; 1982; 80():214-8. PubMed ID: 7036284 [TBL] [Abstract][Full Text] [Related]